Sanofi (SNY)

Press Release : Availability of the aide-mémoire for Q3 2026 results

Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up

As First Dupixent MDL Hearing Opens, Weitz & Luxenberg Points to Sanofi's Own Words on a Cancer That Hides Behind Eczema

Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®

Sanofi, Regeneron Expand Immunology Alliance With New Antibodies

Regeneron And Sanofi Announce A Win-Win Collaboration Expansion

Regeneron, Sanofi Expand Alliance in Deal Worth Up to $8 Billion

Sanofi, Regeneron Expand DUPIXENT Alliance in Deal Worth Up to €8 Billion

Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion

Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential?

Sanofi's New Drugs Poised to Drive Growth Beyond Dupixent

Sanofi Reviews Pipeline, Broadens Deal Hunt as It Rebuilds Research Engine

Sanofi (SAN:CA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Sanofi Reviews Pipeline, Broadens Deal Hunt as It Rebuilds Research Engine

Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent Loss

Sanofi: Stronger Launches And A New R&D Reset Keep The Re-Rating Case Alive

Sanofi (SAN:CA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript